×
More Charts Below
Teligent Total Current Liabilities 2010-2021 | TLGT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Recent Trends
Teligent total current liabilities from 2010 to 2021. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$15.5B
Dr Reddy's Laboratories (RDY)
$11.4B
BridgeBio Pharma (BBIO)
$6.4B
Bausch Health Cos (BHC)
$1.9B
Supernus Pharmaceuticals (SUPN)
$1.7B
Amphastar Pharmaceuticals (AMPH)
$1.1B
Personalis (PSNL)
$282M
Taysha Gene Therapies (TSHA)
$254M
Assembly Biosciences (ASMB)
$75M
Sol-Gel Technologies (SLGL)
$15M
Evoke Pharma (EVOK)
$3M